Long-Term Muscular Atrophy and Weakness Following Cessation of Botulinum Toxin Type A Injections in the Flexor Digitorum Muscle of Musicians with Focal Hand Dystonia Christos I. Ioannou, Franziska L. Hodde-Chriske, Eckart Altenmüller Toxins.2023; 15(4): 296. CrossRef
Abnormal movements “Motare” in Kyudo have the characteristics of task—specific focal dystonia Taichi Ogiso, Yoya Ono, Saiki Suzuki, Takayoshi Shimohata Rinsho Shinkeigaku.2023; 63(8): 532. CrossRef
Blacksmith’s Dystonia Is Another Task-Specific Dystonia: From Past to Present Min Seung Kim, Don Gueu Park, Jung Han Yoon Journal of Movement Disorders.2022; 15(3): 284. CrossRef
Objective Impulse control disorders (ICDs) in Parkinson’s disease (PD) are mostly related to dopamine replacement therapy (DRT); however, drug-naïve PD patients have also frequently experienced impulsivity. This phenomenon makes clinicians hesitate treating patients with DRT. In this study, we assessed the effect of impulsivity on quality of life (QOL) in drug-naïve PD patients.
Methods Two hundred three newly diagnosed, nonmedicated PD patients were enrolled, and they received structured clinical interviews, physical examinations and validated questionnaires to evaluate motor and nonmotor symptoms and QOL. Impulsivity was evaluated using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS).
Results Thirty-eight patients (18.7%) had impulsivity with QUIP-RS scores ≥ 1 and 4 patients (2.0%) were diagnosed with combined ICDs. Motor and nonmotor symptoms were significantly correlated with the Parkinson’s Disease Questionnaire-39 summary index. Female sex and QUIP-RS scores were also correlated with QOL in drug-naïve PD patients.
Conclusion The results of the present study showed that impulsivity negatively influences QOL in early drug-naïve PD patients. In addition, more severe motor and nonmotor symptoms were also associated with lower QOL. Such findings complicate treatment but provide valuable information for managing early PD.
Citations
Citations to this article as recorded by
Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation Weibing Liu, Tatsuya Yamamoto, Yoshitaka Yamanaka, Masato Asahina, Tomoyuki Uchiyama, Shigeki Hirano, Keisuke Shimizu, Yoshinori Higuchi, Satoshi Kuwabara Frontiers in Neurology.2021;[Epub] CrossRef
Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease Alison Hall, Samuel R. Weaver, Lindsey J. Compton, Winston D. Byblow, Ned Jenkinson, Hayley J. MacDonald Clinical Parkinsonism & Related Disorders.2021; 5: 100113. CrossRef
A Review of the Concept of Impulsivity Mohammed Munther Al-Hammouri, Jehad A. Rababah, Celeste Shawler Advances in Nursing Science.2021; 44(4): 357. CrossRef
Assessment of therapeutic strategies for management of impulse control disorder in Parkinson’s disease Mayela Rodríguez-Violante, Yazmín Ríos-Solís, Oscar Esquivel-Zapata, Fanny Herrera, Susana López-Alamillo, Cynthia Sarabia-Tapia, Amin Cervantes-Arriaga Arquivos de Neuro-Psiquiatria.2021; 79(11): 989. CrossRef
High throughput 3D gel-based neural organotypic model for cellular assays using fluorescence biosensors Srikanya Kundu, Molly E. Boutin, Caroline E. Strong, Ty Voss, Marc Ferrer Communications Biology.2022;[Epub] CrossRef